Dialog Box

Skin Health Institute
COVID Vaccines and Inflammatory Skin Disease – What’s the latest

COVID Vaccines and Inflammatory Skin Disease – What’s the latest

7:30PM - 8:30PM Wednesday 3rd March 2021

COVID Vaccines and INFLAMMATORY SKIN DISEASE – What’s the latest?

Associate Professor Chris Blyth, on the back of his briefing to the Australian Medical Association federal council on COVID vaccines, is presenting on SARS-CoV2 vaccines at this unmissable Masterclass. A/Prof Blyth will be presenting on the vaccines and their mechanism of action. In particular, he will address how the vaccines should be utilised in patients with inflammatory skin disease on biologics or immunosuppressants, and their safety for these patients. There will also be discussion on whether patients on biologics should be at the head of the vaccination queue.



Associate Professor Peter Foley is a clinical dermatologist, and has a wealth of experience in dermatology particularly in the treatment of psoriasis. He is Australia’s only councillor on the International Psoriasis Council and served on the steering committee of GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis).

A/Prof Foley currently holds the positions of Associate Professor, Department of Medicine (Dermatology) at The University of Melbourne, Director of Research at the Skin Health Institute and Head, Dermatology Research, St Vincent's Hospital Melbourne. He is a visiting dermatologist at the Photobiology, Phototherapy and Biologics Clinics at St. Vincent's Hospital Melbourne, and the Phototherapy and Biologics Clinics at the Skin Health Institute.

As the Director of Research, A/Prof Foley directs the Institute's rapidly expanding clinical trials program and is co-convenor of the Australasian Psoriasis Registry. To date he has been an author on well over 100 peer reviewed publications, including the reports of many of the pivotal trials of biologics in psoriasis and has been an investigator in over 100 clinical trials, many for new therapies for psoriasis. He is a world-renowned expert on psoriasis and has been invited to speak at numerous meetings in all corners of the globe.



Associate Professor Chris Blyth is a clinician scientist with the Division of Paediatrics in the UWA Medical School. He is a Research Fellow at Telethon Kids Institute, Head of Infectious Diseases at Perth Children’s Hospital, and a Clinical Microbiologist at PathWest Laboratory Medicine. 

Professor Blyth undertook his undergraduate medical degree at UWA before embarking on postgraduate training in paediatrics, infectious diseases and microbiology in Perth and Sydney. He returned to Perth in 2010 as a clinical academic and established the Department of Infectious Diseases at Perth Children’s Hospital. He is an NHMRC Career Development Fellow having previously held a WA Health/Raine Early Career Research Fellowship. 

Professor Blyth also leads an influenza and acute respiratory infection research program undertaking work in Australia and Papua New Guinea. He has been an investigator on grants totalling more than nine million dollars and has been published widely in peer-reviewed journals. Professor Blyth has served on the Australian Technical Advisory Group on Immunisation committee since 2012. 

He is currently co-chair of the group, which is Australia’s peak scientific committee on immunisation. It provides advice to the Commonwealth Department of Health and is tasked with writing the Australian Immunisation Handbook, one of the most utilised clinical guidelines in the country. Professor Blyth is also on the editorial board of the Journal of Pediatric Infectious Diseases Society of America, and is a member of the inaugural class of the Vaccine Fellow Program of the Edwards Jenner Vaccine Society.